Bioceres Crop Solutions (BIOX) Expected to Announce Earnings on Wednesday

Bioceres Crop Solutions (NASDAQ:BIOX - Get Free Report) is projected to release its Q3 2025 earnings data before the market opens on Wednesday, June 4th. Analysts expect Bioceres Crop Solutions to post earnings of ($0.10) per share and revenue of $61.87 million for the quarter.

Bioceres Crop Solutions (NASDAQ:BIOX - Get Free Report) last issued its earnings results on Wednesday, May 21st. The company reported ($0.02) earnings per share (EPS) for the quarter, beating the consensus estimate of ($0.10) by $0.08. The company had revenue of $59.60 million during the quarter, compared to analysts' expectations of $61.80 million. Bioceres Crop Solutions had a return on equity of 0.68% and a net margin of 0.58%. On average, analysts expect Bioceres Crop Solutions to post $0 EPS for the current fiscal year and $0 EPS for the next fiscal year.

Bioceres Crop Solutions Trading Down 1.0%

Shares of NASDAQ:BIOX traded down $0.05 during midday trading on Thursday, reaching $4.96. 42,493 shares of the company's stock were exchanged, compared to its average volume of 174,140. Bioceres Crop Solutions has a fifty-two week low of $3.51 and a fifty-two week high of $11.86. The stock has a market cap of $311.05 million, a price-to-earnings ratio of 248.12 and a beta of 0.40. The company has a debt-to-equity ratio of 0.43, a current ratio of 1.33 and a quick ratio of 0.96. The firm's 50 day simple moving average is $4.38 and its two-hundred day simple moving average is $5.44.

Wall Street Analyst Weigh In

BIOX has been the topic of several recent research reports. Oppenheimer decreased their price objective on shares of Bioceres Crop Solutions from $8.00 to $7.00 and set an "outperform" rating on the stock in a research report on Tuesday, April 22nd. Canaccord Genuity Group decreased their target price on Bioceres Crop Solutions from $7.00 to $6.50 and set a "buy" rating for the company in a report on Thursday, February 13th. Finally, Lake Street Capital cut their target price on shares of Bioceres Crop Solutions from $13.00 to $8.00 and set a "buy" rating on the stock in a research note on Friday, February 7th. Four analysts have rated the stock with a buy rating and two have given a strong buy rating to the company's stock. According to MarketBeat, the stock currently has a consensus rating of "Buy" and a consensus price target of $8.63.

Institutional Inflows and Outflows

A hedge fund recently raised its stake in Bioceres Crop Solutions stock. Jones Financial Companies Lllp raised its stake in Bioceres Crop Solutions Corp. (NASDAQ:BIOX - Free Report) by 3,535.8% in the first quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 5,490 shares of the company's stock after acquiring an additional 5,339 shares during the period. Jones Financial Companies Lllp's holdings in Bioceres Crop Solutions were worth $25,000 as of its most recent SEC filing. 17.68% of the stock is currently owned by hedge funds and other institutional investors.

About Bioceres Crop Solutions

Bioceres Crop Solutions Corp., together with its subsidiaries, provides crop productivity solutions. It operates through Seed and Integrated Products, Crop Protection, and Crop Nutrition segments. The Seed and Integrated Products segment provides seed traits, germplasms, and seed treatment packs for healthier, and higher yielding crops.